All In Biotech

Drug Trial Radar · NCT07385703

Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

A Randomized, Open-Label, Multicenter Phase III Study of Tecotabart Vedotin Plus Tislelizumab Versus Tislelizumab Plus Chemotherapy as First-Line Treatment in Patients With CLDN18.2-Positive, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Last checked: Nov 19, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 752 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

752

Planned (sponsor's estimate)

Start

Apr 15, 2026

Primary completion

Oct 2028

Study completion May 2030

Sponsor

Sponsor type
Industry
First posted
Feb 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study primarily evaluates the efficacy and safety of the LM-302 plus tislelizumab regimen versus tislelizumab plus chemotherapy in the treatment of previously untreated locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma patients with CLDN18.2 positivity.

Conditions

  • Adenocarcinoma

Interventions

  • LM-302 InjectionDrug

    The LM-302 injection is an ADC drug targeting CLDN18.2.

  • TislelizumabDrug

    Tislelizumab is a humanized monoclonal antibody targeting programmed cell death receptor-1 (PD-1).

  • Oxaliplatin InjectionDrug

    Oxaliplatin injection is a platinum-based antitumor drug.

  • Capecitabine TabletsDrug

    Capecitabine tablets belong to the fluorouracil-class prodrugs.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS)Time frame: 1.5 years

Locations

106 sites in 1 country. Site status is shown where the registry gives one.

  • Anhui Provincial Cancer Hospital

    Hefei, Anhui, China · Not yet recruiting

  • Anhui Provincial Cancer Hospital

    Hefei, Anhui, China · Not yet recruiting

  • Anhui Provincial Hospital (The First Affiliated Hospital of China University of Science and Technology)

    Hefei, Anhui, China · Not yet recruiting

  • The Second Hospital Of Anhui Medical University

    Hefei, Anhui, China · Not yet recruiting

  • The First Affiliated Hospital Of Wannan Medical College

    Wuhu, Anhui, China · Not yet recruiting

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Lu He Hospital ,Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Beijing Gaobo Hospital Co., Ltd.

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Beijing Tsinghua changgung Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • Chongqing University Three Gorges Hospital

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • Fujian Cancer Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • Fujian Provincial Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • The First Affiliated Hospital Of Xiamen University

    Xiamen, Fujian, China · Not yet recruiting

  • Gansu Provincial Hospital

    Lanzhou, Gansu, China · Not yet recruiting

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, China · Not yet recruiting

  • Gansu Provincial Cancer Hospital

    Lanzhou, Gansu, China · Not yet recruiting

  • Gansu Wuwei Tumour Hospital

    Wuwei, Gansu, China · Not yet recruiting

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Guangdong provincial people's hospital

    Guangzhou, Guangdong, China · Not yet recruiting

  • The Sixth Affiliated Hospital,Sun Yat-sen University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Meizhou People's Hospital

    Meizhou, Guangdong, China · Not yet recruiting

  • Shantou University Medical College Affiliated Tumor Hospital

    Shantou, Guangdong, China · Not yet recruiting

  • Guigang City People's Hospital

    Guigang, Guangxi, China · Not yet recruiting

  • Guangxi Medical University Afiliated Tomor Hospital

    Nanning, Guangxi, China · Not yet recruiting

  • The People's Hospital of Guizhou Province

    Guiyang, Guizhou, China · Not yet recruiting

  • The Second Affiliated Hospital Of Zunyi Medical University

    Zunyi, Guizhou, China · Not yet recruiting

  • Hainan general hospital

    Haikou, Hainan, China · Not yet recruiting

  • The Second Affiliated Hospital of Hainan Medical University

    Haikou, Hainan, China · Not yet recruiting

  • Affiliated Hospital of Chengde Medical University

    Chengde, Hebei, China · Not yet recruiting

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Not yet recruiting

  • Affiliated Cancer Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Not yet recruiting

  • Jiamusi Tuberculosis Hospital (Jiamusi Cancer Hospital)

    Jiamusi, Heilongjiang, China · Not yet recruiting

  • Anyang Cancer Hospital

    Anyang, Henan, China · Not yet recruiting

  • Luoyang Central Hospital

    Luoyang, Henan, China · Not yet recruiting

  • The First Affiliated Hospital Of Henan University of Science and Technology

    Luoyang, Henan, China · Not yet recruiting

  • Nanyang Second General Hospital

    Nanyang, Henan, China · Not yet recruiting

  • The First affiliated Hospital of Nanyang Medical College

    Nanyang, Henan, China · Not yet recruiting

Showing 40 of 106 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.